查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807411

早期癌症檢測·監測用液態生物檢體的全球市場:市場規模·佔有率·趨勢，產業分析 (生物標記·癌症·各技術·各最終用途·各地區)，2025年～2034年的市場預測

Liquid Biopsy for Early Cancer Detection and Monitoring Market Size, Share, Trends, Industry Analysis Report By Biomarker, By Cancer, By Technology, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 最近的一項研究，預計到 2034 年，用於早期癌症檢測和監測的液體活檢市場規模將達到 65.3 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

液體活檢是一種非侵入性診斷工具，可檢測體液（主要是血液）中的癌症相關生物標記物，從而實現早期癌症檢測和監測。與需要外科手術的傳統組織切片不同，液體切片分析的是循環腫瘤 DNA (ctDNA)、循環腫瘤細胞 (CTC)、外泌體或其他釋放到血液中的癌症衍生分子。該方法提供了一種微創、快速且可重複的方法，用於識別腫瘤相關的基因突變、表觀遺傳學改變和蛋白質特徵。液體活檢尤其適用於早期癌症檢測，可在出現症狀或影像學檢查發現腫瘤之前識別惡性腫瘤。液體切片檢查也用於監測治療反應、檢測微小殘留病灶 (MRD) 並即時追蹤腫瘤進展，幫助臨床醫生根據分子變化製定個人化治療方案。

液體活檢的應用涵蓋各種臨床場景，包括篩檢高風險族群、指導個人化治療以及比傳統方法更早發現復發。在肺癌領域，液體切片正在識別 EGFR 突變，從而客製化酪胺酸激酶抑制劑治療方案。在大腸直腸癌領域，液體活檢有助於監測 KRAS 突變，以確定治療抗藥性。新一代定序 (NGS) 和人工智慧驅動的數據分析的進步正在提高液體活檢的準確性和可擴展性。

用於早期癌症檢測和監測的液體活檢市場：分析概述

就生物標記而言，循環腫瘤DNA (ctDNA) 細分市場預計將佔 2024 年 32.31% 的收入佔有率，這得益於其高靈敏度、廣泛適用於各種癌症類型以及檢測微小殘留病灶和腫瘤異質性的能力。

按癌症類型劃分，肺癌在 2024 年佔了相當大的收入佔有率，這得益於其高發病率、早期檢測的需求以及組織活檢和影像學等傳統診斷方法的局限性。

就技術而言，新一代定序 (NGS) 憑藉其高靈敏度和特異性同時分析多種基因變異的能力，在 2024 年佔了主導地位。

按最終用途劃分，預計診斷實驗室細分市場將在未來幾年保持強勁增長。這些實驗室提供專業知識、經濟高效的檢測解決方案和較短的周轉時間，對醫生和患者都具有吸引力。

預計到 2024 年，北美用於早期癌症檢測和監測的液體活檢市場將佔全球收入的 37.15%。這種主導地位歸因於癌症的高發病率、非侵入性診斷技術的日益普及以及強大的醫療保健基礎設施。

全球早期癌症檢測和監測液體活檢市場的領先公司包括 AnchorDx, Inc.、Burning Rock Biotech Limited、Elypta AB、Exact Sciences Corporation、Freenome Holdings, Inc.、GENEC, Inc.、Illumina, Inc.、Guardant Health、Lucence Health、Myriad Genetics, Inc. 和 Oncipune, Inc.

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球早期癌症檢測·監測用液態生物檢體市場洞察

  • 市場概述
  • 早期癌症檢測·監測用液態生物檢體的市場動態
    • 促進因素和機會
      • 癌症發生率上升
      • 監管支持力道加大
    • 阻礙因素和課題
      • 檢測低濃度腫瘤衍生物質的敏感度有限
  • 大環境分析
  • 早期癌症檢測·監測用液態生物檢體市場趨勢
  • 價值鏈分析

第5章 全球早期癌症檢測·監測用液態生物檢體市場:生物標記

  • 主要的分析結果
  • 簡介
  • 循環腫瘤DNA (ctDNA)
  • 循環腫瘤細胞 (CTC)
  • 外泌體/微囊泡
  • 循環蛋白質

第6章 全球早期癌症檢測·監測用液態生物檢體市場:癌症

  • 主要的分析結果
  • 簡介
  • 肺癌症
  • 乳癌
  • 大腸癌症
  • 前列腺癌症
  • 其他

第7章 全球早期癌症檢測·監測用液態生物檢體市場:各技術

  • 主要的分析結果
  • 簡介
  • 次世代定序(NGS)
  • PCR為基礎的化驗
  • 微陣列
  • 表觀基因/甲基化化驗
  • 其他

第8章 全球早期癌症檢測·監測用液態生物檢體市場:各最終用途

  • 主要的分析結果
  • 簡介
  • 醫院
  • 診斷檢驗室
  • 其他

第9章 全球早期癌症檢測·監測用液態生物檢體市場:各地區

  • 主要的分析結果
  • 簡介
    • 早期癌症檢測·監測用液態生物檢體市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:各生物標記(2020～2034年)
    • 北美:各癌症(2020～2034年)
    • 北美:各技術(2020～2034年)
    • 北美:各最終用途(2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各生物標記(2020～2034年)
    • 歐洲:各癌症(2020～2034年)
    • 歐洲:各技術(2020～2034年)
    • 歐洲:各最終用途(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各生物標記(2020～2034年)
    • 亞太地區:各癌症(2020～2034年)
    • 亞太地區:各技術(2020～2034年)
    • 亞太地區:各最終用途(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各生物標記(2020～2034年)
    • 中東·非洲:各癌症(2020～2034年)
    • 中東·非洲:各技術(2020～2034年)
    • 中東·非洲:各最終用途(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各生物標記(2020～2034年)
    • 南美:各癌症(2020～2034年)
    • 南美:各技術(2020～2034年)
    • 南美:各最終用途(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • AnchorDx
  • Burning Rock Biotech Limited
  • Elypta AB
  • Exact Sciences Corporation
  • Freenome Holdings, Inc.
  • GENECAST
  • Guardant Health
  • Illumina, Inc.
  • Lucence Health Inc.
  • Myriad Genetics, Inc.
  • M42
  • Oncimmune
Product Code: PM6201

The liquid biopsy for early cancer detection and monitoring market size is expected to reach USD 6.53 billion by 2034, according to a new study by Polaris Market Research. The report "Liquid Biopsy for Early Cancer Detection and Monitoring Market Share, Size, Trends, Industry Analysis Report By Biomarker [Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)], By Cancer, By Technology, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Liquid biopsy is a noninvasive diagnostic tool that detects cancer-related biomarkers in bodily fluids, primarily blood, to enable early cancer detection and monitoring. Unlike traditional tissue biopsies, which require surgical procedures, liquid biopsies analyze circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, or other cancer-derived molecules released into the bloodstream. This approach offers a less invasive, faster, and repeatable method for identifying genetic mutations, epigenetic changes, and protein signatures associated with tumors. Liquid biopsies are particularly valuable for early cancer detection, as they identify malignancies before symptoms appear or imaging tests reveal tumors. They are also used to monitor treatment response, detect minimal residual disease (MRD), and track tumor evolution in real-time, helping clinicians adjust therapies based on molecular changes.

The usage of liquid biopsies spans various clinical scenarios, including screening high-risk individuals, guiding personalized treatment, and detecting relapse earlier than conventional methods. In lung cancer, liquid biopsies identify EGFR mutations to tailor tyrosine kinase inhibitor therapy. In colorectal cancer, they help monitor KRAS mutations for resistance to treatment. Advancements in next-generation sequencing (NGS) and AI-driven data analysis are enhancing the accuracy and scalability of liquid biopsy.

Liquid Biopsy for Early Cancer Detection and Monitoring Market Report Highlights

In terms of biomarker, the circulating tumor DNA (ctDNA) segment held 32.31% of the revenue share in 2024 due to its high sensitivity, broad applicability across cancer types, and ability to detect minimal residual disease and tumor heterogeneity.

Based on cancer, the lung cancer segment accounted for a major revenue share in 2024 due to the high incidence of the disease, need for early detection, and the limitations of traditional diagnostic methods such as tissue biopsy and imaging.

In terms of technology, the next-generation sequencing (NGS) segment dominated the revenue share in 2024 due to its capability to analyze multiple genetic alterations simultaneously with high sensitivity and specificity.

Based on end use, the diagnostic laboratories segment is projected to grow at a robust pace in the coming years. These laboratories offer specialized expertise, cost-effective testing solutions, and shorter turnaround times, making them attractive for both physicians and patients.

The North America liquid biopsy for early cancer detection and monitoring market accounted for 37.15% of global revenue share in 2024. This dominance is attributed to the high prevalence of cancer, increasing adoption of noninvasive diagnostic techniques, and strong healthcare infrastructure.

A few global key players in the liquid biopsy for early cancer detection and monitoring market include AnchorDx; Burning Rock Biotech Limited; Elypta AB; Exact Sciences Corporation; Freenome Holdings, Inc.; GENECAST; Illumina, Inc.; Guardant Health; Lucence Health Inc.; Myriad Genetics, Inc.; and Oncimmune.

Polaris Market Research has segmented the liquid biopsy for early cancer detection and monitoring market report on the basis of biomarker, cancer, technology, end use, and region:

By Biomarker Outlook (Revenue, USD Billion, 2020-2034)

Circulating Tumor DNA (ctDNA)

Circulating Tumor Cells (CTCs)

Exosomes/Microvesicles

Circulating Proteins

By Cancer Outlook (Revenue, USD Billion, 2020-2034)

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Others

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Next-Generation Sequencing (NGS)

PCR-based assays

Microarray

Epigenomics / Methylation assays

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market Insights

  • 4.1. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Market Snapshot
  • 4.2. Liquid Biopsy for Early Cancer Detection and Monitoring Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Cancer Incidence
      • 4.2.1.2. Growing Regulatory Support
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited sensitivity in detecting low levels of tumor-derived material
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market Trends
  • 4.6. Value Chain Analysis

5. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • 5.3. Circulating Tumor DNA (ctDNA)
    • 5.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Tumor DNA (ctDNA), by Region, 2020-2034 (USD Billion)
  • 5.4. Circulating Tumor Cells (CTCs)
    • 5.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Tumor Cells (CTCs), by Region, 2020-2034 (USD Billion)
  • 5.5. Exosomes/Microvesicles
    • 5.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Exosomes/Microvesicles, by Region, 2020-2034 (USD Billion)
  • 5.6. Circulating Proteins
    • 5.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Circulating Proteins, by Region, 2020-2034 (USD Billion)

6. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • 6.3. Lung Cancer
    • 6.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 6.4. Breast Cancer
    • 6.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 6.5. Colorectal Cancer
    • 6.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 6.6. Prostate Cancer
    • 6.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Next-Generation Sequencing (NGS)
    • 7.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 7.4. PCR-based assays
    • 7.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by PCR-based assays, by Region, 2020-2034 (USD Billion)
  • 7.5. Microarray
    • 7.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Microarray, by Region, 2020-2034 (USD Billion)
  • 7.6. Epigenomics / Methylation assays
    • 7.6.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Epigenomics / Methylation assays, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Liquid Biopsy for Early Cancer Detection and Monitoring Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Liquid Biopsy for Early Cancer Detection and Monitoring Market - North America
    • 9.3.1. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.3.2. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.3.3. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.3.4. North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - US
      • 9.3.5.1. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Canada
      • 9.3.6.1. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Europe
    • 9.4.1. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - UK
      • 9.4.5.1. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - France
      • 9.4.6.1. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Germany
      • 9.4.7.1. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Italy
      • 9.4.8.1. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Spain
      • 9.4.9.1. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Netherlands
      • 9.4.10.1. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Russia
      • 9.4.11.1. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Asia Pacific
    • 9.5.1. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - China
      • 9.5.5.1. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - India
      • 9.5.6.1. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Malaysia
      • 9.5.7.1. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Japan
      • 9.5.8.1. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Indonesia
      • 9.5.9.1. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Liquid Biopsy for Early Cancer Detection and Monitoring Market - South Korea
      • 9.5.10.1. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Australia
      • 9.5.11.1. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - UAE
      • 9.6.6.1. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Israel
      • 9.6.7.1. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - South Africa
      • 9.6.8.1. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Latin America
    • 9.7.1. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Mexico
      • 9.7.5.1. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Brazil
      • 9.7.6.1. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Argentina
      • 9.7.7.1. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Liquid Biopsy for Early Cancer Detection and Monitoring Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AnchorDx
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Burning Rock Biotech Limited
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Elypta AB
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Exact Sciences Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Freenome Holdings, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GENECAST
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Guardant Health
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Illumina, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Lucence Health Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Myriad Genetics, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. M42
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Oncimmune
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 2 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 3 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 6 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 7 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 8 North America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 10 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 11 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 12 U.S.: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 14 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 15 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 Canada: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 18 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 19 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 20 Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 22 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 23 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 UK: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 26 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 27 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 France: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 30 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 31 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 32 Germany: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 34 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 35 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 36 Italy: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 38 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 39 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Spain: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 46 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 47 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 48 Russia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 58 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 59 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 60 China: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 62 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 63 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 India: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 70 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 71 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 72 Japan: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 78 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 79 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 80 South Korea: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 82 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 83 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Australia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 98 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 99 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 100 UAE: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 102 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 103 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 104 Israel: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 106 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 107 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 108 South Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 114 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 115 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 116 Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 118 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 119 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 120 Mexico: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 122 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 123 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 124 Brazil: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 126 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 127 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 128 Argentina: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Biomarker
  • Figure 7. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Cancer
  • Figure 9. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Liquid Biopsy for Early Cancer Detection and Monitoring Market, by End Use, 2024 & 2034 (USD Billion)